SII seeks inclusion of COVID jab Covovax in CoWIN portal as heterologous booster dose for adults Read more
DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster dose Read more
US FDA grants EUA for Novavax COVID-19 vaccine, adjuvanted for adolescents aged 12 through 17 years Read more
Phase-III trials of Novavax’s vaccine show high levels of protection against infection: Research head Read more